Biocompatible crosslinked composition
View Patent ↗Crosslinked polymer compositions comprise a first synthetic polymer containing multiple nucleophilic groups covalently bound to a second synthetic polymer containing multiple electrophilic groups. The first synthetic polymer is preferably a synthetic polypeptide or a polyethylene glycol that has been modified to contain multiple nucleophilic groups, such as primary amino (—NH 2 )or thiol (—SH) groups. The second synthetic polymer may be a hydrophilic or hydrophobic synthetic polymer which contains, or has been derivatized to contain, two or more electrophilic groups, such as succinimidyl groups. The compositions may further comprise other components, such as naturally occurring polysaccharides or proteins (such as glycosaminoglycans or collagen) and/or biologically active agents. Also disclosed are methods for using the crosslinked polymmer compositions to effect adhesion between a first surface and a second surface; to effect tissue augmentation; to prevent the formation of surgical adhesions; and to coat a surface of a synthetic implant.
1. A method for preparing a biocompatible crosslinked composition, comprising admixing, under crosslinking conditions, (a) a first crosslinkable component having m nucleophilic groups, wherein m≧2, with (b) a second crosslinkable component having n electrophilic groups capable of reaction with the m nucleophilic groups to form covalent bonds, wherein n≧2 and m+n≧5, wherein each of the first and second crosslinkable components is biocompatible and synthetic, and crosslinking of the components results in the biocompatible crosslinked composition.
2. The method of claim 1 , wherein the m nucleophilic groups in the first crosslinkable component are identical.
3. The method of claim 1 , wherein at least two of the m nucleophilic groups in the first crosslinkable component are different.
4. The method of claim 1 , wherein the n electrophilic groups in the second crosslinkable component are identical.
5. The method of claim 2 , wherein the n electrophilic groups in the second crosslinkable component are identical.
6. The method of claim 3 , wherein the n electrophilic groups in the second crosslinkable component are identical.
7. The method of claim 1 , wherein at least two of the n electrophilic groups in the second crosslinkable component are different.
8. The method of claim 2 , wherein at least two of the n electrophilic groups in the second crosslinkable component are different.
9. The method of claim 3 , wherein at least two of the n electrophilic groups in the second crosslinkable component are different.
10. The method of claim 1 , wherein the m nucleophilic groups are bound to the first crosslinkable component through linking groups.
11. The method of claim 1 , wherein the n electrophilic groups are bound to the second crosslinkable component through linking groups.
12. The method of claim 1 , wherein at least one of the first and second crosslinkable components is comprised of a hydrophilic polymer.
13. The method of claim 1 , wherein at least one of the first and second crosslinkable components is comprised of a hydrophobic polymer.
14. The method of claim 1 , wherein the m nucleophilic groups are primary amino groups.
15. The method of claim 14 , wherein the first crosslinkable component is C 2 –C 6 hydrocarbyl substituted with amino groups.
16. The method of claim 14 , wherein the first crosslinkable component is a secondary or tertiary amine NR 1 R 2 R 3 wherein R 1 is hydrogen or an amino-substituted lower alkyl group, and R 2 and R 3 are amino-substituted lower alkyl groups.
17. The method of claim 14 , wherein the n electrophilic groups are selected from the group consisting of succinimidyl ester, sulfosuccinimidyl ester, maleimido, epoxy, isocyanato, thioisocyanato, and ethenesulfonyl.
18. The method of claim 17 , wherein the n electrophilic groups are selected from the group consisting of succinimidyl ester and sulfosuccinimidyl ester.
19. The method of claim 1 , wherein the m nucleophilic groups are sulfhydryl groups.
20. The method of claim 19 , wherein the n electrophilic groups are sulfhydryl-reactive groups selected so as to form a thioester, thioether, or disulfide linkage upon reaction with the sulfhydryl groups.
21. The method of claim 1 , wherein n=2.
22. The method of claim 1 , wherein m=2.
23. The method of claim 1 , wherein the crosslinking conditions comprise admixture in an aqueous medium.
24. The method of claim 23 , wherein the first and second crosslinkable components each represent about 0.5 wt. % to about 20 wt. % of the composition formed upon admixture.
25. The method of claim 23 , wherein the crosslinking conditions further comprise admixture at a pH in the range of 7 to 8.
26. The method of claim 25 , wherein the first and second crosslinkable components are at concentrations of 20 mg/ml to 200 mg/ml of the composition formed upon admixture.
27. The method of claim 1 , wherein the first crosslinkable component is in an aqueous solution, the second crosslinkable component is in dry, particulate form, and admixing comprises combining the second crosslinkable component with the aqueous solution of the first crosslinkable component.
28. The method of claim 27 , the first and second crosslinkable components each represent about 0.5 wt. % to about 20 wt. % of the composition formed upon admixture.
29. The method of claim 27 , wherein the crosslinking conditions further comprise admixture at a pH in the range of 7 to 8.
30. The method of claim 29 , wherein the first and second crosslinkable components are at concentrations of 20 mg/ml to 200 mg/ml of the composition formed upon admixture.
31. The method of claim 1 , wherein the first crosslinkable component is present in a molar excess relative to the second crosslinkable component.
32. The method of claim 1 , wherein the second crosslinkable component is present in a molar excess relative to the first crosslinkable component.
33. A biocompatible crosslinked composition prepared by the process comprising admixing, under crosslinking conditions, (a) a first crosslinkable component having m nucleophilic groups, wherein m≧2 with (b) a second crosslinkable component having n electrophilic groups capable of reaction with the m nucleophilic groups to form covalent bonds, wherein n≧2 and m+n≧5, wherein each of the first and second crosslinkable components is biocompatible and synthetic, and crosslinking of the components results in the biocompatible crosslinked composition.
34. The composition of claim 33 , wherein the m nucleophilic groups in the first crosslinkable component are identical.
35. The composition of claim 33 , wherein at least two of the m nucleophilic groups in the first crosslinkable component are different.
36. The composition of claim 33 , wherein the n electrophilic groups in the second crosslinkable component are identical.
37. The composition of claim 34 , wherein the n electrophilic groups in the second crosslinkable component are identical.
38. The composition of claim 35 , wherein the n electrophilic groups in the second crosslinkable component are identical.
39. The composition of claim 33 , wherein at least two of the n electrophilic groups in the second crosslinkable component are different.
40. The composition of claim 34 , wherein at least two of then electrophilic groups in the second crosslinkable component are different.
41. The composition of claim 35 , wherein at least two of the n electrophilic groups in the second crosslinkable component are different.
42. The composition of claim 33 , wherein the m nucleophilic groups are bound to the first crosslinkable component through linking groups.
43. The composition of claim 33 , wherein the n electrophilic groups are bound to the second crosslinkable component through linking groups.
44. The composition of claim 33 , wherein at least one of the first and second crosslinkable components is comprised of a hydrophilic polymer.
45. The composition of claim 33 , wherein at least one of the first and second crosslinkable components is comprised of a hydrophobic polymer.
46. The composition of claim 33 , wherein the m nucleophilic groups are primary amino groups.
47. The composition of claim 46 , wherein the first crosslinkable component is C 2 –C 6 hydrocarbyl substituted with amino groups.
48. The composition of claim 46 , wherein the first crosslinkable component is a secondary or tertiary amine NR 1 R 2 R 3 wherein R 1 is hydrogen or an amino-substituted lower alkyl group, and R 2 and R 3 are amino-substituted lower alkyl groups.
49. The composition of claim 46 , wherein the n electrophilic groups are selected from the group consisting of succinimidyl ester, sulfosuccinimidyl ester, maleimido, epoxy, isocyanato, thioisocyanato, and ethenesulfonyl.
50. The composition of claim 49 , wherein the n electrophilic groups are selected from the group consisting of succinimidyl ester and sulfosuccinimidyl ester.
51. The composition of claim 33 , wherein the m nucleophilic groups are sulfhydryl groups.
52. The composition of claim 51 , wherein the n electrophilic groups are sulfhydryl-reactive groups selected so as to form a thioester, thioether, or disulfide linkage upon reaction with the sulfhydryl groups.
53. The composition of claim 33 , wherein n=2.
54. The composition of claim 33 , wherein m=2.
55. The composition of claim 33 , wherein the crosslinking conditions comprise admixture in an aqueous medium.
56. The composition of claim 55 , wherein the first and second crosslinkable components each represent about 0.5 wt. % to about 20 wt. % of the composition formed upon admixture.
57. The composition of claim 55 , wherein the crosslinking conditions further comprise admixture at a pH in the range of 7 to 8.
58. The composition of claim 57 , wherein the first and second crosslinkable components are at concentrations of 20 mg/ml to 200 mg/ml of the composition formed upon admixture.
59. The composition of claim 33 , wherein the first crosslinkable component is in an aqueous solution, the second crosslinkable component is in dry, particulate form, and admixing comprises combining the second crosslinkable component with the aqueous solution of the first crosslinkable component.
60. The composition of claim 59 , the first and second crosslinkable components each represent about 0.5 wt. % to about 20 wt. % of the composition formed upon admixture.
61. The composition of claim 59 , wherein the crosslinking conditions further comprise admixture at a pH in the range of 7 to 8.
62. The composition of claim 61 , wherein the first and second crosslinkable components are at concentrations of 20 mg/ml to 200 mg/ml of the composition formed upon admixture.
63. The composition of claim 33 , wherein the first crosslinkable component is present in a molar excess relative to the second crosslinkable component.
64. The composition of claim 33 , wherein the second crosslinkable component is present in a molar excess relative to the first crosslinkable component.